Purdue Signs On To Market Labopharm's Once-Daily Tramadol
This article was originally published in The Pink Sheet Daily
Executive Summary
Labopharm will receive up to $170 mil. under the licensing deal, including $20 mil. up front and $40 mil. upon NDA approval.